Companies: 10,795·Total market cap: $144.5T
CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc.

CASINASDAQHealthcare
$0.15
+$0.00(+3.08%)
Market Cap$2331664
P/E Ratio—
52W High$3.09
52W Low$0.135
EmployeesOwnershipInsider Trades

CASI Pharmaceuticals, Inc. (CASI) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CASI · as of May 15, 2026

Latest filing snapshot

200,000
+0+0.00%vs prior year

CASI Pharmaceuticals, Inc. (CASI) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global
Total Employees
200,000
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$143
Net Income / Employee
$-196
Market Cap
$2M

CASI Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-05-15200,000+0+0.00%
2025-03-31200,000+0+0.00%
2024-03-28200,000+0+0.00%
2023-04-26200,000——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
CASI Pharmaceuticals, Inc.
CASI
CASI Pharmaceuticals, Inc.YOU
200,000#2
Curis, Inc.
CRIS
Curis, Inc.
34#3
Clearside Biomedical, Inc.
CLSD
Clearside Biomedical, Inc.
32#4
Cingulate Inc.
CING
Cingulate Inc.
13#5
Allarity Therapeutics, Inc.
ALLR
Allarity Therapeutics, Inc.
6#6
Entero Therapeutics, Inc.
ENTO
Entero Therapeutics, Inc.
2#7
Kairos Pharma, Ltd.
KAPA
Kairos Pharma, Ltd.
1
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CASI peer comparison

About CASI employees

CASI Employees · Headcount

CASI Pharmaceuticals, Inc. (CASI) employee data is sourced from the annual SEC 20-F filing. As of 2025, CASI Pharmaceuticals, Inc. had 200,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

CASI Pharmaceuticals, Inc. employs 200,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $143, reflecting the company's operational efficiency.

CASI Pharmaceuticals, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CASI Pharmaceuticals, Inc.'s revenue per employee of $143 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

CASI Employees · 5 questions

As of the latest SEC 20-F filing (2025), CASI Pharmaceuticals, Inc. had 200,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CASI Pharmaceuticals, Inc. employee counthow many employees does CASI Pharmaceuticals, Inc. haveCASI total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-05-15